Skip to main content
OpenTrials
Completed

NCT Number: NCT05052281

Promoting Healthy Brain Development: Wellness for 2 Study

The "Promoting Healthy Brain Project" (PHBP) is part of the Lurie Children's Hospital Strategic Research Initiative on Perinatal Origins of Childhood Disease: Research & Prevention at the Maternal-Fetal Interface. The overall purpose of the PHBP is to test whether reducing maternal stress during pregnancy is associated with improved neurodevelopment in the first year of life. This will be tested via a randomized controlled trial (n = 100) of a technology and mindfulness enhanced prenatal stress-reduction intervention (Mothers and Babies; MB).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Loading trial locations.

About this study

The "Promoting Healthy Brain Project" (PHBP) aims to improve infant neurodevelopmental trajectories by intervening on the fetal environment. The PHBP will experimentally test whether reducing prenatal maternal stress is associated with improved neurodevelopment in the first year of life. A randomized controlled trial (RCT) of a technology and mindfulness-enhanced prenatal maternal stress-reduction intervention (The Mothers and Babies Course; MB), compared to usual prenatal care. Prospective evaluation of infant neurodevelopmental outcomes will take place through infant age 24 months. Participants assigned to the intervention group will be offered the 12-session MB intervention, a well-studied intervention that will include new mindfulness practice enhancements designed to promote practice of awareness and attention to the present moment. MB visits will be delivered 1-on-1 by a trained facilitator in an open and nonjudgmental way, and will be offered in-person, over the phone, and/or by video chat. Throughout the intervention, all participants (intervention group and control group) will also wear a wireless, "smart" health sensing device (BioStamp Sensor - nPoint Device) that will measure heart rate and motion. Mothers' heart rate variability and self-reported stress and emotion will be monitored using the BioStamp Sensor and brief smartphone surveys. For mothers in the intervention group, patterns of prolonged stress will trigger a "just-in-time adapted intervention" (JITAI) that will be delivered to mothers' smartphones. The booster intervention will include activities that will enhance skills learned in the MB course. All participants will complete self-report measures of prenatal maternal stress, emotion, depression, and skills related to the intervention (e.g., mindfulness). Infant neurodevelopmental health will be measured via brain and behavioral indicators of self-regulation, including performance-based indicators of executive function and corollary prefrontal cortex maturation and dimensional phenotypes of disruptive behavior, particularly irritability.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 18 years old;
  • enrolled under 22 weeks gestation;
  • receiving prenatal care from a Northwestern University prenatal care clinic & planning to deliver at Northwestern Hospitals;
  • English-speaking
  • Participants must own a smartphone and be must be willing to receive text messages and respond to short online surveys using their smartphone.
  • Eligible participants must also agree to wear a wireless adhesive sensor, the BioStamp, daily, throughout the 12-week MB course.
  • Eligible participants will also have WiFi internet access for the duration of their participation in the study, in order to complete online questionnaires and upload sensor data.
  • Eligible participants must also agree to have their child participate in the neurodevelopmental assessments from birth-12 months.

Exclusion criteria

  • Women will be ineligible to participate in this study if they have known pregnancy or chronic medical complications that may place their infant at risk for neurological disorders (e.g., HIV; acute cytomegalovirus infection (CMV); toxoplasmosis; zika virus; Phenylketonuria (PKU); chromosomal anomalies; metabolic disorder; substance use disorders) or significant mental health disorders (e.g., schizophrenia, bipolar disorder, psychosis) which could interfere with study adherence.
  • Participants unable to wear the BioStamp Sensor due to known skin sensitivity (e.g., allergy to adhesives or silicone), current skin irritation, or broken skin at the placement site will not be eligible to participate.
  • Participants with a pacemaker or other sensitive medical device will be excluded.
  • Women will not be eligible to participate if unable to provide informed consent, complete MB sessions, or complete study assessments in English.
  • Women who are currently participating in an MB course at the time of recruitment will not be eligible to participate.

Treatment and study plan

Mothers and Babies (MB) Course

Behavioral

The Mothers and Babies course (MB) is a 12-session manualized stress-reduction intervention that will be delivered to participants, prenatally, with an integrated technology suite designed for timely detection and response to maternal stress.

Just in Time Intervention (JITI) Content

Behavioral

Participants will also receive additional MB intervention content in the form of "just-in-time" text messages, which will be sent to participants' smartphones every other day for up to 12 weeks. During the current trial, participants will receive text message prompts with links to additional stress reduction content based on a combination of their objective (sensor) and subjective (EMA) stress responses from the previous day.

BioStamp nPoint device

Device

During the intervention period, participants will be asked to wear the BioStamp nPoint sensor, daily, while engaging in their usual activities (e.g., sleep, showering, exercise). The BioStamp Sensor is a thin, wearable patch, equipped with wireless high-range 6-axis gyroscope + accelerometer, and sEMG and ECG sensors, that adheres to the skin using a disposable medical-grade adhesive sticker (with adhesive similar to Band-Aid).

Primary outcomes

  1. Disruptive Behavior Diagnostic Observation Schedule (DB DOS)

    Time frame: 12 months, 24 months

    The DB DOS is a standardized observation of infant arousal, soothability, reactivity, and temper loss. During early infancy, the

  2. Perceived Stress Scale (PSS)

    Time frame: Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

    The PSS is a self-report measure of the degree to which an individual perceives their life situations to be stressful. The instrument includes 10 items that assess how unpredictable, uncontrollable, and overloaded respondents find their lives, and assess current levels of experienced stress.

  3. MAP-DB

    Time frame: 1 month, 7 months, 12 months, 24 months

    Parent report measure of infant irritability.

  4. PROMIS Depression

    Time frame: Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

    Mothers complete a 28-item scale that assesses depressive symptoms experienced in the past 7 days.

  5. State Trait Anxiety Inventory (STAI)

    Time frame: Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

    The STAI is a 40 item self report questionnaire that assesses both state anxiety and trait anxiety.

Secondary outcomes

  1. Five Facet Mindfulness Questionnaire (FFMQ)

    Time frame: Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

    The FFMQ is a 39-item self report survey that taps into five areas of mindfulness, including observation, description, aware actions, non-judgmental inner experience, and non-reactivity.

  2. NICU Neonatal Behavioral Scale (NNNS)

    Time frame: 1 month

    The NNNS is an assessment of neurobehavioral organization, neurological reflexes, motor development - active and passive tone, and signs of stress and withdrawal in neonates, developed for use with at-risk or drug-exposed infants but has been normed with typically developing infants.

  3. Test of Infant Motor Performance (TIMP)

    Time frame: 1 month

    The TIMP is a norm-referenced measure designed to evaluate motor control and organization of posture and movement for functional activities in infants 32 weeks gestational age to four months post-term age and measures both spontaneous behaviors and elicited items.

  4. General Movements Assessment (GMA)

    Time frame: 1 month

    General movements are a developmentally regulated pattern of spontaneous motor activity. By 10-15 weeks of age, the predominant general movements seen are called Fidgety Movements - a pattern of continuous, small amplitude movements of the neck, trunk and limbs during wakefulness that disappear with agitation. These patterns are identifiable and are classified as normal if present (intermittent or continual), and abnormal if exaggerated (with respect to speed and amplitude), sporadic (interspersed with long pauses) or absent. Babies are observed for up to 30 minutes in a supine position to assess for spontaneous movements.

  5. Alberta Infant Motor Scale (AIMS)

    Time frame: 1 month

    The Alberta Infant Motor Scale (AIMS) is a 10-20 minute norm referenced, standardized, gross motor assessment. Infants are observed in four positions: prone, sitting, supine, and standing. For each subscale, items are scored as "observed" or "not observed". A total raw score and percentile are calculated.

  6. Maternal Heart Rate Variability

    Time frame: Pregnancy (duration 14 weeks)

    variability/physiological stress as indicated by a machine learned model applied to electrocardiogram (ECG) signals.

  7. Prefrontal cortex thickness

    Time frame: 1 month, 12 months, 24 months

    Cortical thickness and surface area of pre-frontal cortex regions, which have been linked to child irritability and Infant dysregulation, is measured through natural sleep MRI.

  8. Inflammatory and neuroimmune biomarkers

    Time frame: At birth

    Placenta and cord blood will be collected at birth. Tests to be performed on these samples include measurement of inflammatory markers related to stress, such as a multiplex immunoassay panel of the following cytokines and chemokines: (IL-6, IL-8, IL-10, C-reactive protein, TNF-alpha, TGF-beta, IL-1beta, procalcitonin, cortisol).

  9. EEG power

    Time frame: 1 month, 12 months, 24 months

    The baby will complete a baseline or resting EEG for 2-5 minutes and then hear an auditory oddball paradigm with speech syllables while resting for ~10 min. EEG (electroencephalogram) power will be measured as a marker infant neurodevelopment.

  10. ERP mean amplitude

    Time frame: 1 month, 12 months, 24 months

    The baby will complete a baseline or resting EEG for 2-5 minutes and then hear an auditory oddball paradigm with speech syllables while resting for ~10 min. ERP (event related potential) mean amplitude will be measured as a marker of infant neurodevelopment.

  11. Birthweight

    Time frame: Birth

    Infant birthweight will be obtained from EHR data collected at the hospital at birth

  12. Maternal Infant Responsiveness Instrument (MIRI)

    Time frame: 1 month, 7 months, 12 months

    The MIRI is a 22 item questionnaire designed to assess a mother's feelings about her infant, her recognition of her responsiveness to the infant, and her infants responses.

  13. Infant Behavior Questionnaire-Revised (IBQ-R) short form

    Time frame: 1 month, 7 months, 12 months

    The IBQ-R is a parent-report survey designed to measure multiple dimensions of temperament in infants up to age 12 months.

  14. Bayley Scales of Infant Development

    Time frame: 7 months, 12 months, 24 months

    The Bayley Scales of Infant and Toddler Development Fourth Edition (Bayley-4) is a five-domain assessment tool used to determine developmental delays in children. The developmental domains are cognitive, language, motor, social-emotional, and adaptive behavior, and include direct assessment of the child and parent report.

  15. Preschool Age Psychiatric Assessment (PAPA)

    Time frame: 24 months

    Parent structured interview for diagnosing psychiatric disorders in children ages 2-5.

  16. Brief Infant Toddler Social Emotional Assessment (BITSEA)

    Time frame: 12 months, 24 months

    Parent report measure of behavior problems and social competencies in children ages 1-3 that identifies delays or deficits in areas of social-emotional development.

  17. Early Childhood Irritability Related Impairment Interview (E-CRI)

    Time frame: 24 months

    The E-CRI is a semi-structured interview designed to measure early childhood impairment resulting from young children's tantrums and irritability across various contexts.

  18. Perceived Stress Scale (PSS)

    Time frame: 1 month, 3 months, 7 months, 12 months, 24 months

    Self-report measure of the degree to which an individual perceives their life situations to be stressful. The instrument includes 10 items that assess how unpredictable, uncontrollable, and overloaded respondents find their lives, and assess current levels of experienced stress.

  19. Behavioral Activation Depression Scale (BADS) - short form

    Time frame: prenatal, 3 months, 7 months, 12 months, 24 months

    Self-report 9-item measure of behaviors that indicate depression and can be targeted for change by cognitive behavioral therapy and behavior activation. Mothers complete this measure regarding behaviors experienced over the past week.

  20. Negative Mood Regulation Scale (NMRS)

    Time frame: prenatal, 3 months, 7 months, 12 months, 24 months

    This self-report, 30-item scale measures expectancies and beliefs that the mothers have regarding their abilities to alleviate their negative mood, anger, anxiety and depression.

  21. Parenting Stress Index (PSI) - Role Restriction Subscale

    Time frame: 3 months, 7 months, 12 months, 24 months

    The PSI Role Restriction subscale includes 7 mother-report items regarding her feelings of limited freedom and restriction of her identity to the parenting role.

  22. Parental Cognitions and Conduct Toward the Infant Scale (PACOTIS)

    Time frame: 1 month, 3 months, 7 months, and 12 months

    The PACOTIS is a mother report measure of their actions, thoughts, and feelings during interactions with their baby.

  23. MacArthur-Bates Communicative Development Inventories (MCDI)

    Time frame: 12 months, 24 months

    The MCDI is a parent-report questionnaire about their child's communication and language development. The Words & Gestures form is used at 12 months and the Words & Sentences form is used at 24 months.

  24. Medical Outcomes Study (MOS) Social Support Survey

    Time frame: Prenatal, 3 months, 7 months, 12 months, 24 months

    The MOS Social Support Survey is a 19-item self-report measure of the mother's availability of social support in a variety of domains including emotional support, tangible support, affectionate support, and positive social interaction.

Other outcomes

  1. Family Life Impairment Scale (FLIS)

    Time frame: 12 months, 24 months

    The FLIS is a parent report survey that assesses the degree to which a child's behavior impacts the family's ability to participate in typical activities.

  2. PROMIS Anxiety

    Time frame: Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

    Mothers complete the PROMIS Anxiety scale, which includes items that assess fear, anxious misery, hyperarousal, and somatic symptoms related to anxiety.

  3. Family Relationship Index (FRI)

    Time frame: prenatal, 3 months, 7 months, 12 months, 24 months

    The FRI is a 12-item survey designed to assess family cohesion, communication and conflict-resolution.

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

Registry information

Official study title

Promoting Healthy Brain Development Via Prenatal Stress Reduction: An Innovative Precision Medicine Approach

Important dates

Study start
2019
Primary completion
2024
Study completion
2024
First posted
Sep 22, 2021
Registry last updated
Feb 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.